Noteworthy - December 2022


Providence scientist recognized for legacy of public service
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, has been awarded the 2022 Society of Immunotherapy of Cancer (SITC) Tara Withington Public Service Award. The honor is given to an individual who fosters and enhances the field of cancer immunotherapy through public awareness and research.

“One of my passions has been to bridge the tumor immunology/cancer immunotherapy community across geographic and political barriers, to improve communication and scientific exchange, augment educational opportunities, and overcome hurdles to the translation of novel science into trials for patients with cancer,” said Dr. Fox.

Dr. Fox received the award in November at the annual SITC22 conference, which draws leading cancer immunotherapy and tumor immunology professionals from around the world.

PMG-Gateway Family Medicine serves patients facing food insecurity
Elizabeth O’Neill, M.D., from Providence Medical Group-Gateway in Portland, talks about how her clinic works with a local emergency food pantry to donate food to clinic patients in need. The clinic recognizes that plentiful, healthy food is key to its patients who face food insecurity. Watch the interview here.

Providence among few sites worldwide offering new trials for solid tumors and lung cancer
The Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, has a robust early phase clinical trials portfolio that includes immunotherapies, targeted therapies and other novel agents under investigation. Learn about some new trials for solid tumors and lung cancer here.

Kevin Olson, M.D., named CMO of Providence Central Division Institutes and Programs
Kevin Olson, M.D., has been named as the new chief medical officer for Providence Central Division Institutes and Programs. He most recently served as chief executive of clinical programs for Providence – Oregon. In his new position, Dr. Olson leads specialty care in the areas of cancer, heart, women and children, and neuroscience for the Central Division of eastern Washington, Montana, Oregon, Texas and New Mexico. Read more here. (link available only to Providence employees)

“Healing Hillary’s Heart” illustrates how Providence Heart Institute makes a difference
Lifesaving answers sometimes can be uncovered through innovative cardiac research. Providence Heart Institute’s care team and research from the Cardiovascular Analytics Research and Data Sciences program helped save 29-year-old Hillary’s life. Generous donors help fund CARDS research and the latest innovations at Providence Heart Institute. Read Hillary’s story here.

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.

More Content by Providence inScope Content Team
Previous Article
InScope – December 2022: Letter from physician leaders
InScope – December 2022: Letter from physician leaders

As we approach the end of 2022, please know how much we value and appreciate the care and compassion you pr...

Next Article
New radiation technology for cancer patients requires only five treatments
New radiation technology for cancer patients requires only five treatments

Providence Cancer Institute now can treat cancer patients with new radiotherapy technology that delivers mo...